Declining Prevalence of Trichomonas vaginalis Diagnosed by Wet Mount in a Cohort of US Women With and Without HIV

被引:0
作者
Daubert, Elizabeth M. [1 ]
Dionne, Jodie [2 ]
Atrio, Jessica [3 ,4 ]
Knittel, Andrea K. [5 ]
Kassaye, Seble G. [6 ]
Seidman, Dominika [7 ]
Long, Amanda [8 ]
Brockmann, Susan [9 ]
Ofotokun, Igho [10 ]
Fischl, Margaret A. [11 ]
Massad, L. Stewart [12 ,13 ]
Weber, Kathleen M. [1 ,14 ]
机构
[1] Cook Cty Hlth Hektoen Inst Med, Chicago, IL USA
[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA
[3] Montefiore Hosp, Bronx, NY USA
[4] Albert Einstein Coll Med, Bronx, NY USA
[5] Univ North Carolina Chapel Hill, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC USA
[6] Georgetown Univ, Dept Med, Washington, DC USA
[7] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA
[8] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[9] SUNY Hlth Sci Univ, Brooklyn, NY USA
[10] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA
[11] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL USA
[12] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO USA
[13] Washington Univ, Sch Med, Dept Obstet & Gynecol, St. Louis, MO 63110 USA
[14] Cook Cty Hlth Hektoen Inst Med, Chicago, IL 60608 USA
关键词
Trichomonas vaginalis; vaginal discharge; human immunodeficiency virus infection in women; INTERAGENCY HIV; HIGH-RISK; PERSISTENCE; INFECTIONS; CARE;
D O I
10.1089/jwh.2023.0263
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Women living with HIV (WLWH) are often coinfected with Trichomonas vaginalis (TV), and annual screening is recommended. Our goal was to assess differences in TV prevalence at study entry and over time in enrollment cohorts of the Women's Interagency HIV Study. Methods: In a multisite study, TV was diagnosed by wet mount microscopy. Prevalence was determined across four enrollment waves: 1994-1995, 2001-2002, 2011-2012, and 2013-2015. Generalized estimating equation multivariable logistic regression models assessed changes in visit prevalence across waves after controlling for HIV disease severity and other risks. Results: At 63,824 person-visits (3,508 WLWH and 1,262 women without HIV), TV was diagnosed by wet mount at 1979 visits (3.1%). After multivariable adjustment, HIV status was not associated with TV detection, which was more common among younger women, women with multiple partners, and irregular condom use. All enrollment waves showed a decline in TV detection over time, although p-value for trend did not reach significance for most recent waves. To explore the potential utility of screening among WLWH, we assessed rates of TV detection among women without appreciable vaginal discharge on examination. Initial TV prevalence among asymptomatic women was 3.5%, and prevalence decreased to 0.5%-1% in the most recent wave (2013-2015) (p-trend <0.0001). Conclusions: In this cohort, TV rates are low among WLWH, and HIV does not increase TV risk. Screening may benefit newly diagnosed WLWH, women with risk factors, or those receiving care sporadically but is unlikely to further reduce the low rate of TV among women in care, especially older women without multiple partners. The clinical trials registration number for WIHS is NCT00000797.
引用
收藏
页码:388 / 395
页数:8
相关论文
共 18 条
  • [1] Cohort Profile: The Women's Interagency HIV Study (WIHS)
    Adimora, Adaora A.
    Ramirez, Catalina
    Benning, Lorie
    Greenblatt, Ruth M.
    Kempf, Mirjam-Colette
    Tien, Phyllis C.
    Kassaye, Seble G.
    Anastos, Kathryn
    Cohen, Mardge
    Minkoff, Howard
    Wingood, Gina
    Ofotokun, Igho
    Fischl, Margaret A.
    Gange, Stephen
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) : 393 - +
  • [2] [Anonymous], Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HTV Medicine Association of the Infectious Diseases Society of America
  • [3] The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench
    Bacon, MC
    von Wyl, V
    Alden, C
    Sharp, G
    Robison, E
    Hessol, N
    Gange, S
    Barranday, Y
    Holman, S
    Weber, K
    Young, MA
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (09) : 1013 - 1019
  • [4] The Women's Interagency HIV Study
    Barkan, SE
    Melnick, SL
    Preston-Martin, S
    Weber, K
    Kalish, LA
    Miotti, P
    Young, M
    Greenblatt, R
    Sacks, H
    Feldman, J
    [J]. EPIDEMIOLOGY, 1998, 9 (02) : 117 - 125
  • [5] Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection
    Cu-Uvin, S
    Ko, HJ
    Jamieson, DJ
    Hogan, JW
    Schuman, P
    Anderson, J
    Klein, RS
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) : 1406 - 1411
  • [6] Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men
    Gaydos, Charlotte A.
    Klausner, Jeffrey D.
    Pai, Nitika Pant
    Kelly, Helen
    Coltart, Cordelia
    Peeling, Rosanna W.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 : S31 - S35
  • [7] Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues
    Kissinger, Patricia
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [8] Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort
    Lazenby, Gweneth B.
    Hill, Allyson
    Tarleton, Jessica
    Soper, David
    [J]. SEXUALLY TRANSMITTED DISEASES, 2020, 47 (05) : 332 - 337
  • [9] Cost-Effectiveness Analysis of Annual Trichomonas vaginalis Screening and Treatment in HIV-Positive Women to Prevent HIV Transmission
    Lazenby, Gweneth Bratton
    Unal, Elizabeth Ramsey
    Andrews, Annie Lintzenich
    Simpson, Kit
    [J]. SEXUALLY TRANSMITTED DISEASES, 2014, 41 (06) : 353 - 358
  • [10] Trichomonas vaginalis among HIV-infected women -: Are immune status or protease inhibitor use associated with subsequent T-vaginalis positivity?
    Magnus, M
    Clark, R
    Myers, L
    Farley, T
    Kissinger, PJ
    [J]. SEXUALLY TRANSMITTED DISEASES, 2003, 30 (11) : 839 - 843